nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—SCNN1G—sweat—psoriasis	0.165	0.7	CbGeAlD
Amiloride—PLAU—Dissolution of Fibrin Clot—SERPINB8—psoriasis	0.0622	0.263	CbGpPWpGaD
Amiloride—PLAU—endothelium—psoriasis	0.0246	0.104	CbGeAlD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IVL—psoriasis	0.0173	0.0735	CbGpPWpGaD
Amiloride—ASIC2—tendon—psoriasis	0.0139	0.059	CbGeAlD
Amiloride—SLC9A1—skin of body—psoriasis	0.0111	0.047	CbGeAlD
Amiloride—PLAU—skin of body—psoriasis	0.0105	0.0445	CbGeAlD
Amiloride—AOC1—Tryptophan metabolism—CAT—psoriasis	0.00971	0.0411	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—ITGAL—psoriasis	0.0095	0.0402	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IL23A—psoriasis	0.00905	0.0383	CbGpPWpGaD
Amiloride—PLAU—tendon—psoriasis	0.008	0.0339	CbGeAlD
Amiloride—PLAU—Endochondral Ossification—RUNX3—psoriasis	0.00547	0.0231	CbGpPWpGaD
Amiloride—PLAU—Osteopontin Signaling—NFKB1—psoriasis	0.00473	0.02	CbGpPWpGaD
Amiloride—PLAU—Beta2 integrin cell surface interactions—ICAM1—psoriasis	0.00393	0.0166	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—NOS2—psoriasis	0.00372	0.0157	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—NFKBIA—psoriasis	0.0037	0.0157	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—ICAM1—psoriasis	0.00363	0.0154	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINB8—psoriasis	0.00332	0.0141	CbGpPWpGaD
Amiloride—SLC22A4—tendon—psoriasis	0.00281	0.0119	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—IL10—psoriasis	0.00251	0.0106	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—JUN—psoriasis	0.00247	0.0104	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—JUN—psoriasis	0.00245	0.0104	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL4—psoriasis	0.00244	0.0104	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—NFKB1—psoriasis	0.00236	0.00999	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—NFKB1—psoriasis	0.0023	0.00974	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—psoriasis	0.00229	0.00969	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—HLA-A—psoriasis	0.00221	0.00938	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—NOS2—psoriasis	0.00221	0.00935	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—psoriasis	0.00213	0.00901	CbGpPWpGaD
Amiloride—SLC9A1—RhoA signaling pathway—JUN—psoriasis	0.00202	0.00854	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CAT—psoriasis	0.00187	0.00791	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—CP—psoriasis	0.00179	0.00758	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—TNF—psoriasis	0.00179	0.00757	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.00177	0.0075	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—CP—psoriasis	0.00176	0.00745	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Clobetasol propionate—psoriasis	0.00173	0.0968	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Clobetasol propionate—psoriasis	0.00173	0.0968	CbGdCrCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—CARM1—psoriasis	0.00171	0.00723	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IFNG—psoriasis	0.00169	0.00717	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—PCNA—psoriasis	0.00166	0.00702	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—VEGFA—psoriasis	0.00165	0.00698	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.00163	0.00689	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—CXCL8—psoriasis	0.00158	0.00667	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—JUN—psoriasis	0.00157	0.00666	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—JUN—psoriasis	0.00154	0.00652	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IFNG—psoriasis	0.00148	0.00626	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—JUN—psoriasis	0.00146	0.0062	CbGpPWpGaD
Amiloride—PLAU—amb2 Integrin signaling—IL6—psoriasis	0.00144	0.00611	CbGpPWpGaD
Amiloride—PLAU—Betamethasone—Beclomethasone—psoriasis	0.00139	0.0775	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Fluocinonide—psoriasis	0.00139	0.0775	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Beclomethasone—psoriasis	0.00139	0.0775	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Fluocinonide—psoriasis	0.00139	0.0775	CbGdCrCtD
Amiloride—PLAU—AP-1 transcription factor network—CXCL8—psoriasis	0.00137	0.00582	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—STAT3—psoriasis	0.00136	0.00576	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CP—psoriasis	0.00136	0.00574	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CP—psoriasis	0.00136	0.00574	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CP—psoriasis	0.00136	0.00574	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CP—psoriasis	0.00136	0.00574	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CP—psoriasis	0.00136	0.00574	CbGpPWpGaD
Amiloride—PLAU—Betamethasone—Fluocinolone Acetonide—psoriasis	0.00135	0.0754	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.00135	0.0754	CbGdCrCtD
Amiloride—PLAU—Wnt Signaling Pathway—JUN—psoriasis	0.00132	0.0056	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—CARM1—psoriasis	0.00129	0.00548	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—CARM1—psoriasis	0.00129	0.00548	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—CARM1—psoriasis	0.00129	0.00548	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—CARM1—psoriasis	0.00129	0.00548	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—CARM1—psoriasis	0.00129	0.00548	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—psoriasis	0.00129	0.00544	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—JUN—psoriasis	0.00128	0.00541	CbGpPWpGaD
Amiloride—PLAU—Endochondral Ossification—VEGFA—psoriasis	0.0012	0.00508	CbGpPWpGaD
Amiloride—PLAU—Beta1 integrin cell surface interactions—VEGFA—psoriasis	0.00117	0.00495	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IFNG—psoriasis	0.00107	0.00452	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—JUN—psoriasis	0.00102	0.00434	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CXCL8—psoriasis	0.000993	0.00421	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITGAL—psoriasis	0.000965	0.00409	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NDUFA5—psoriasis	0.000962	0.00407	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—JUN—psoriasis	0.000945	0.004	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—JUN—psoriasis	0.000923	0.00391	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—JUN—psoriasis	0.000896	0.0038	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CP—psoriasis	0.000894	0.00379	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—STAT3—psoriasis	0.000886	0.00375	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—IL6—psoriasis	0.000885	0.00375	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—NFKB1—psoriasis	0.000863	0.00365	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000853	0.00361	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—psoriasis	0.000843	0.00357	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000838	0.00355	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2S1—psoriasis	0.000818	0.00346	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—CP—psoriasis	0.000805	0.00341	CbGpPWpGaD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000781	0.00331	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL6—psoriasis	0.000772	0.00327	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Hydrocortisone—psoriasis	0.000681	0.0381	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Hydrocortisone—psoriasis	0.000681	0.0381	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Dexamethasone—psoriasis	0.000632	0.0353	CbGdCrCtD
Amiloride—PLAU—Dexamethasone—Betamethasone—psoriasis	0.000632	0.0353	CbGdCrCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—psoriasis	0.000624	0.00264	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Triamcinolone—psoriasis	0.000618	0.0345	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Triamcinolone—psoriasis	0.000618	0.0345	CbGdCrCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—psoriasis	0.00061	0.00258	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—psoriasis	0.000592	0.00251	CbGpPWpGaD
Amiloride—PLAU—Dexamethasone—Prednisone—psoriasis	0.000586	0.0328	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisone—psoriasis	0.000586	0.0328	CbGdCrCtD
Amiloride—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000573	0.00112	CcSEcCtD
Amiloride—PLAU—Dexamethasone—Prednisolone—psoriasis	0.000572	0.032	CbGdCrCtD
Amiloride—PLAU—Betamethasone—Prednisolone—psoriasis	0.000572	0.032	CbGdCrCtD
Amiloride—Fatigue—Mycophenolic acid—psoriasis	0.000572	0.00112	CcSEcCtD
Amiloride—Asthenia—Hydroxyurea—psoriasis	0.000568	0.00111	CcSEcCtD
Amiloride—Pain—Mycophenolic acid—psoriasis	0.000567	0.00111	CcSEcCtD
Amiloride—Constipation—Mycophenolic acid—psoriasis	0.000567	0.00111	CcSEcCtD
Amiloride—Palpitations—Mycophenolate mofetil—psoriasis	0.000567	0.00111	CcSEcCtD
Amiloride—Arthralgia—Cyclosporine—psoriasis	0.00056	0.0011	CcSEcCtD
Amiloride—Chest pain—Cyclosporine—psoriasis	0.00056	0.0011	CcSEcCtD
Amiloride—Cough—Mycophenolate mofetil—psoriasis	0.00056	0.0011	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—psoriasis	0.000558	0.00236	CbGpPWpGaD
Amiloride—Depression—Prednisone—psoriasis	0.000555	0.00109	CcSEcCtD
Amiloride—Visual impairment—Betamethasone—psoriasis	0.000553	0.00108	CcSEcCtD
Amiloride—Visual impairment—Dexamethasone—psoriasis	0.000553	0.00108	CcSEcCtD
Amiloride—Feeling abnormal—Mycophenolic acid—psoriasis	0.000547	0.00107	CcSEcCtD
Amiloride—Chest pain—Mycophenolate mofetil—psoriasis	0.000546	0.00107	CcSEcCtD
Amiloride—Arthralgia—Mycophenolate mofetil—psoriasis	0.000546	0.00107	CcSEcCtD
Amiloride—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000542	0.00106	CcSEcCtD
Amiloride—Diarrhoea—Hydroxyurea—psoriasis	0.000542	0.00106	CcSEcCtD
Amiloride—Confusional state—Cyclosporine—psoriasis	0.000541	0.00106	CcSEcCtD
Amiloride—Vertigo—Prednisolone—psoriasis	0.000537	0.00105	CcSEcCtD
Amiloride—Back pain—Triamcinolone—psoriasis	0.000532	0.00104	CcSEcCtD
Amiloride—Confusional state—Mycophenolate mofetil—psoriasis	0.000528	0.00104	CcSEcCtD
Amiloride—Vertigo—Hydrocortisone—psoriasis	0.000525	0.00103	CcSEcCtD
Amiloride—Abdominal pain—Mycophenolic acid—psoriasis	0.000524	0.00103	CcSEcCtD
Amiloride—Dizziness—Hydroxyurea—psoriasis	0.000524	0.00103	CcSEcCtD
Amiloride—Shock—Mycophenolate mofetil—psoriasis	0.000515	0.00101	CcSEcCtD
Amiloride—Anorexia—Cyclosporine—psoriasis	0.000511	0.001	CcSEcCtD
Amiloride—Bradycardia—Prednisone—psoriasis	0.000508	0.000997	CcSEcCtD
Amiloride—Alopecia—Dexamethasone—psoriasis	0.000507	0.000994	CcSEcCtD
Amiloride—Alopecia—Betamethasone—psoriasis	0.000507	0.000994	CcSEcCtD
Amiloride—Vomiting—Hydroxyurea—psoriasis	0.000503	0.000988	CcSEcCtD
Amiloride—Haemoglobin—Prednisone—psoriasis	0.000502	0.000985	CcSEcCtD
Amiloride—Haemorrhage—Prednisone—psoriasis	0.000499	0.00098	CcSEcCtD
Amiloride—Rash—Hydroxyurea—psoriasis	0.000499	0.000979	CcSEcCtD
Amiloride—Anorexia—Mycophenolate mofetil—psoriasis	0.000499	0.000979	CcSEcCtD
Amiloride—Dermatitis—Hydroxyurea—psoriasis	0.000499	0.000978	CcSEcCtD
Amiloride—Headache—Hydroxyurea—psoriasis	0.000496	0.000973	CcSEcCtD
Amiloride—Vertigo—Triamcinolone—psoriasis	0.000494	0.00097	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000489	0.000959	CcSEcCtD
Amiloride—Dysuria—Methotrexate—psoriasis	0.000488	0.000956	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—psoriasis	0.000488	0.000956	CcSEcCtD
Amiloride—Insomnia—Cyclosporine—psoriasis	0.000485	0.000952	CcSEcCtD
Amiloride—Paraesthesia—Cyclosporine—psoriasis	0.000482	0.000945	CcSEcCtD
Amiloride—Shock—Prednisolone—psoriasis	0.00048	0.000942	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—psoriasis	0.00048	0.000942	CcSEcCtD
Amiloride—Cough—Triamcinolone—psoriasis	0.00048	0.000942	CcSEcCtD
Amiloride—Dyspnoea—Cyclosporine—psoriasis	0.000478	0.000938	CcSEcCtD
Amiloride—Somnolence—Cyclosporine—psoriasis	0.000477	0.000936	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000477	0.000935	CcSEcCtD
Amiloride—Asthenia—Mycophenolic acid—psoriasis	0.000476	0.000933	CcSEcCtD
Amiloride—Insomnia—Mycophenolate mofetil—psoriasis	0.000473	0.000929	CcSEcCtD
Amiloride—Dyspepsia—Cyclosporine—psoriasis	0.000472	0.000926	CcSEcCtD
Amiloride—Nausea—Hydroxyurea—psoriasis	0.00047	0.000923	CcSEcCtD
Amiloride—Paraesthesia—Mycophenolate mofetil—psoriasis	0.00047	0.000922	CcSEcCtD
Amiloride—Pruritus—Mycophenolic acid—psoriasis	0.000469	0.00092	CcSEcCtD
Amiloride—Shock—Hydrocortisone—psoriasis	0.000469	0.00092	CcSEcCtD
Amiloride—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000467	0.000915	CcSEcCtD
Amiloride—Decreased appetite—Cyclosporine—psoriasis	0.000466	0.000915	CcSEcCtD
Amiloride—Somnolence—Mycophenolate mofetil—psoriasis	0.000465	0.000913	CcSEcCtD
Amiloride—Depression—Methotrexate—psoriasis	0.000464	0.000909	CcSEcCtD
Amiloride—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000463	0.000909	CcSEcCtD
Amiloride—Fatigue—Cyclosporine—psoriasis	0.000463	0.000907	CcSEcCtD
Amiloride—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000461	0.000904	CcSEcCtD
Amiloride—Constipation—Cyclosporine—psoriasis	0.000459	0.0009	CcSEcCtD
Amiloride—Pain—Cyclosporine—psoriasis	0.000459	0.0009	CcSEcCtD
Amiloride—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000455	0.000892	CcSEcCtD
Amiloride—Anorexia—Hydrocortisone—psoriasis	0.000455	0.000892	CcSEcCtD
Amiloride—Diarrhoea—Mycophenolic acid—psoriasis	0.000454	0.00089	CcSEcCtD
Amiloride—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000452	0.000886	CcSEcCtD
Amiloride—Vertigo—Dexamethasone—psoriasis	0.000448	0.00088	CcSEcCtD
Amiloride—Vertigo—Betamethasone—psoriasis	0.000448	0.00088	CcSEcCtD
Amiloride—Constipation—Mycophenolate mofetil—psoriasis	0.000448	0.000878	CcSEcCtD
Amiloride—Pain—Mycophenolate mofetil—psoriasis	0.000448	0.000878	CcSEcCtD
Amiloride—Feeling abnormal—Cyclosporine—psoriasis	0.000442	0.000867	CcSEcCtD
Amiloride—Shock—Triamcinolone—psoriasis	0.000442	0.000866	CcSEcCtD
Amiloride—Insomnia—Prednisolone—psoriasis	0.000442	0.000866	CcSEcCtD
Amiloride—Alopecia—Prednisone—psoriasis	0.000441	0.000866	CcSEcCtD
Amiloride—Gastrointestinal pain—Cyclosporine—psoriasis	0.000439	0.000861	CcSEcCtD
Amiloride—Dizziness—Mycophenolic acid—psoriasis	0.000439	0.00086	CcSEcCtD
Amiloride—Paraesthesia—Prednisolone—psoriasis	0.000438	0.00086	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000434	0.000852	CcSEcCtD
Amiloride—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000431	0.000846	CcSEcCtD
Amiloride—Insomnia—Hydrocortisone—psoriasis	0.000431	0.000846	CcSEcCtD
Amiloride—Paraesthesia—Hydrocortisone—psoriasis	0.000428	0.00084	CcSEcCtD
Amiloride—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000428	0.00084	CcSEcCtD
Amiloride—Abdominal pain—Cyclosporine—psoriasis	0.000424	0.000832	CcSEcCtD
Amiloride—Vomiting—Mycophenolic acid—psoriasis	0.000422	0.000827	CcSEcCtD
Amiloride—Dyspepsia—Hydrocortisone—psoriasis	0.00042	0.000823	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—psoriasis	0.000419	0.000823	CcSEcCtD
Amiloride—Rash—Mycophenolic acid—psoriasis	0.000418	0.00082	CcSEcCtD
Amiloride—Dermatitis—Mycophenolic acid—psoriasis	0.000418	0.00082	CcSEcCtD
Amiloride—Pain—Prednisolone—psoriasis	0.000418	0.000819	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—psoriasis	0.000417	0.000819	CcSEcCtD
Amiloride—Headache—Mycophenolic acid—psoriasis	0.000415	0.000815	CcSEcCtD
Amiloride—Decreased appetite—Hydrocortisone—psoriasis	0.000415	0.000813	CcSEcCtD
Amiloride—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000414	0.000812	CcSEcCtD
Amiloride—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000412	0.000808	CcSEcCtD
Amiloride—Fatigue—Hydrocortisone—psoriasis	0.000411	0.000806	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CP—psoriasis	0.000409	0.00173	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000409	0.000802	CcSEcCtD
Amiloride—Pain—Hydrocortisone—psoriasis	0.000408	0.0008	CcSEcCtD
Amiloride—Insomnia—Triamcinolone—psoriasis	0.000406	0.000797	CcSEcCtD
Amiloride—Paraesthesia—Triamcinolone—psoriasis	0.000403	0.000791	CcSEcCtD
Amiloride—Feeling abnormal—Prednisolone—psoriasis	0.000402	0.000789	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—psoriasis	0.000402	0.000789	CcSEcCtD
Amiloride—Shock—Betamethasone—psoriasis	0.000401	0.000786	CcSEcCtD
Amiloride—Shock—Dexamethasone—psoriasis	0.000401	0.000786	CcSEcCtD
Amiloride—Dyspnoea—Triamcinolone—psoriasis	0.0004	0.000785	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CARM1—psoriasis	0.0004	0.00169	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS2—psoriasis	0.000396	0.00168	CbGpPWpGaD
Amiloride—Dyspepsia—Triamcinolone—psoriasis	0.000395	0.000775	CcSEcCtD
Amiloride—Nausea—Mycophenolic acid—psoriasis	0.000394	0.000773	CcSEcCtD
Amiloride—Feeling abnormal—Hydrocortisone—psoriasis	0.000393	0.000771	CcSEcCtD
Amiloride—Vertigo—Prednisone—psoriasis	0.000391	0.000766	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—CARM1—psoriasis	0.00039	0.00165	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Hydrocortisone—psoriasis	0.00039	0.000765	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—psoriasis	0.000389	0.000763	CcSEcCtD
Amiloride—Anorexia—Dexamethasone—psoriasis	0.000388	0.000762	CcSEcCtD
Amiloride—Anorexia—Betamethasone—psoriasis	0.000388	0.000762	CcSEcCtD
Amiloride—Fatigue—Triamcinolone—psoriasis	0.000387	0.000759	CcSEcCtD
Amiloride—Asthenia—Cyclosporine—psoriasis	0.000385	0.000755	CcSEcCtD
Amiloride—Pain—Triamcinolone—psoriasis	0.000384	0.000753	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000381	0.00161	CbGpPWpGaD
Amiloride—Pruritus—Cyclosporine—psoriasis	0.00038	0.000745	CcSEcCtD
Amiloride—Abdominal pain—Hydrocortisone—psoriasis	0.000377	0.000739	CcSEcCtD
Amiloride—Asthenia—Mycophenolate mofetil—psoriasis	0.000376	0.000737	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000371	0.000728	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000371	0.000728	CcSEcCtD
Amiloride—Pruritus—Mycophenolate mofetil—psoriasis	0.00037	0.000726	CcSEcCtD
Amiloride—Arthralgia—Prednisone—psoriasis	0.00037	0.000726	CcSEcCtD
Amiloride—Feeling abnormal—Triamcinolone—psoriasis	0.00037	0.000726	CcSEcCtD
Amiloride—Alopecia—Methotrexate—psoriasis	0.000369	0.000723	CcSEcCtD
Amiloride—Insomnia—Betamethasone—psoriasis	0.000368	0.000723	CcSEcCtD
Amiloride—Insomnia—Dexamethasone—psoriasis	0.000368	0.000723	CcSEcCtD
Amiloride—Diarrhoea—Cyclosporine—psoriasis	0.000367	0.00072	CcSEcCtD
Amiloride—Paraesthesia—Dexamethasone—psoriasis	0.000366	0.000718	CcSEcCtD
Amiloride—Paraesthesia—Betamethasone—psoriasis	0.000366	0.000718	CcSEcCtD
Amiloride—Dyspepsia—Betamethasone—psoriasis	0.000359	0.000703	CcSEcCtD
Amiloride—Dyspepsia—Dexamethasone—psoriasis	0.000359	0.000703	CcSEcCtD
Amiloride—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000358	0.000702	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000355	0.0015	CbGpPWpGaD
Amiloride—Dizziness—Cyclosporine—psoriasis	0.000355	0.000696	CcSEcCtD
Amiloride—Decreased appetite—Dexamethasone—psoriasis	0.000354	0.000695	CcSEcCtD
Amiloride—Decreased appetite—Betamethasone—psoriasis	0.000354	0.000695	CcSEcCtD
Amiloride—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000352	0.00069	CcSEcCtD
Amiloride—Gastrointestinal disorder—Betamethasone—psoriasis	0.000352	0.00069	CcSEcCtD
Amiloride—Back pain—Methotrexate—psoriasis	0.000351	0.000689	CcSEcCtD
Amiloride—Fatigue—Betamethasone—psoriasis	0.000351	0.000689	CcSEcCtD
Amiloride—Fatigue—Dexamethasone—psoriasis	0.000351	0.000689	CcSEcCtD
Amiloride—Shock—Prednisone—psoriasis	0.000349	0.000685	CcSEcCtD
Amiloride—Pain—Dexamethasone—psoriasis	0.000348	0.000683	CcSEcCtD
Amiloride—Pain—Betamethasone—psoriasis	0.000348	0.000683	CcSEcCtD
Amiloride—Dizziness—Mycophenolate mofetil—psoriasis	0.000346	0.000679	CcSEcCtD
Amiloride—Asthenia—Hydrocortisone—psoriasis	0.000342	0.000671	CcSEcCtD
Amiloride—Vomiting—Cyclosporine—psoriasis	0.000341	0.000669	CcSEcCtD
Amiloride—Rash—Cyclosporine—psoriasis	0.000338	0.000664	CcSEcCtD
Amiloride—Anorexia—Prednisone—psoriasis	0.000338	0.000663	CcSEcCtD
Amiloride—Dermatitis—Cyclosporine—psoriasis	0.000338	0.000663	CcSEcCtD
Amiloride—Pruritus—Hydrocortisone—psoriasis	0.000337	0.000662	CcSEcCtD
Amiloride—Headache—Cyclosporine—psoriasis	0.000336	0.000659	CcSEcCtD
Amiloride—Feeling abnormal—Dexamethasone—psoriasis	0.000336	0.000659	CcSEcCtD
Amiloride—Feeling abnormal—Betamethasone—psoriasis	0.000336	0.000659	CcSEcCtD
Amiloride—Gastrointestinal pain—Betamethasone—psoriasis	0.000333	0.000653	CcSEcCtD
Amiloride—Gastrointestinal pain—Dexamethasone—psoriasis	0.000333	0.000653	CcSEcCtD
Amiloride—Vomiting—Mycophenolate mofetil—psoriasis	0.000333	0.000653	CcSEcCtD
Amiloride—Rash—Mycophenolate mofetil—psoriasis	0.00033	0.000647	CcSEcCtD
Amiloride—Dermatitis—Mycophenolate mofetil—psoriasis	0.00033	0.000647	CcSEcCtD
Amiloride—Headache—Mycophenolate mofetil—psoriasis	0.000328	0.000643	CcSEcCtD
Amiloride—Vertigo—Methotrexate—psoriasis	0.000326	0.00064	CcSEcCtD
Amiloride—Diarrhoea—Hydrocortisone—psoriasis	0.000326	0.00064	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Prednisone—psoriasis	0.000323	0.000634	CcSEcCtD
Amiloride—Dizziness—Prednisolone—psoriasis	0.000323	0.000633	CcSEcCtD
Amiloride—Asthenia—Triamcinolone—psoriasis	0.000322	0.000632	CcSEcCtD
Amiloride—Abdominal pain—Betamethasone—psoriasis	0.000322	0.000632	CcSEcCtD
Amiloride—Abdominal pain—Dexamethasone—psoriasis	0.000322	0.000632	CcSEcCtD
Amiloride—Insomnia—Prednisone—psoriasis	0.000321	0.000629	CcSEcCtD
Amiloride—Nausea—Cyclosporine—psoriasis	0.000319	0.000625	CcSEcCtD
Amiloride—Paraesthesia—Prednisone—psoriasis	0.000319	0.000625	CcSEcCtD
Amiloride—Pruritus—Triamcinolone—psoriasis	0.000318	0.000623	CcSEcCtD
Amiloride—Cough—Methotrexate—psoriasis	0.000317	0.000622	CcSEcCtD
Amiloride—Dizziness—Hydrocortisone—psoriasis	0.000315	0.000619	CcSEcCtD
Amiloride—Dyspepsia—Prednisone—psoriasis	0.000312	0.000613	CcSEcCtD
Amiloride—Nausea—Mycophenolate mofetil—psoriasis	0.000311	0.00061	CcSEcCtD
Amiloride—Chest pain—Methotrexate—psoriasis	0.000309	0.000607	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—psoriasis	0.000309	0.000607	CcSEcCtD
Amiloride—Decreased appetite—Prednisone—psoriasis	0.000308	0.000605	CcSEcCtD
Amiloride—Rash—Prednisolone—psoriasis	0.000308	0.000604	CcSEcCtD
Amiloride—Dermatitis—Prednisolone—psoriasis	0.000308	0.000603	CcSEcCtD
Amiloride—Fatigue—Prednisone—psoriasis	0.000306	0.0006	CcSEcCtD
Amiloride—Headache—Prednisolone—psoriasis	0.000306	0.0006	CcSEcCtD
Amiloride—Constipation—Prednisone—psoriasis	0.000303	0.000595	CcSEcCtD
Amiloride—Vomiting—Hydrocortisone—psoriasis	0.000303	0.000595	CcSEcCtD
Amiloride—Rash—Hydrocortisone—psoriasis	0.000301	0.00059	CcSEcCtD
Amiloride—Dermatitis—Hydrocortisone—psoriasis	0.0003	0.000589	CcSEcCtD
Amiloride—Confusional state—Methotrexate—psoriasis	0.000299	0.000586	CcSEcCtD
Amiloride—Headache—Hydrocortisone—psoriasis	0.000299	0.000586	CcSEcCtD
Amiloride—Dizziness—Triamcinolone—psoriasis	0.000297	0.000582	CcSEcCtD
Amiloride—Feeling abnormal—Prednisone—psoriasis	0.000292	0.000573	CcSEcCtD
Amiloride—Asthenia—Dexamethasone—psoriasis	0.000292	0.000573	CcSEcCtD
Amiloride—Asthenia—Betamethasone—psoriasis	0.000292	0.000573	CcSEcCtD
Amiloride—Gastrointestinal pain—Prednisone—psoriasis	0.00029	0.000569	CcSEcCtD
Amiloride—Nausea—Prednisolone—psoriasis	0.00029	0.000569	CcSEcCtD
Amiloride—Pruritus—Dexamethasone—psoriasis	0.000288	0.000565	CcSEcCtD
Amiloride—Pruritus—Betamethasone—psoriasis	0.000288	0.000565	CcSEcCtD
Amiloride—Vomiting—Triamcinolone—psoriasis	0.000285	0.00056	CcSEcCtD
Amiloride—Nausea—Hydrocortisone—psoriasis	0.000283	0.000556	CcSEcCtD
Amiloride—Rash—Triamcinolone—psoriasis	0.000283	0.000555	CcSEcCtD
Amiloride—Dermatitis—Triamcinolone—psoriasis	0.000283	0.000555	CcSEcCtD
Amiloride—Anorexia—Methotrexate—psoriasis	0.000283	0.000554	CcSEcCtD
Amiloride—Headache—Triamcinolone—psoriasis	0.000281	0.000552	CcSEcCtD
Amiloride—Abdominal pain—Prednisone—psoriasis	0.00028	0.00055	CcSEcCtD
Amiloride—Diarrhoea—Betamethasone—psoriasis	0.000279	0.000547	CcSEcCtD
Amiloride—Diarrhoea—Dexamethasone—psoriasis	0.000279	0.000547	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00027	0.00053	CcSEcCtD
Amiloride—Dizziness—Dexamethasone—psoriasis	0.000269	0.000528	CcSEcCtD
Amiloride—Dizziness—Betamethasone—psoriasis	0.000269	0.000528	CcSEcCtD
Amiloride—Insomnia—Methotrexate—psoriasis	0.000268	0.000526	CcSEcCtD
Amiloride—Nausea—Triamcinolone—psoriasis	0.000267	0.000523	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—psoriasis	0.000266	0.000522	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—psoriasis	0.000264	0.000519	CcSEcCtD
Amiloride—Somnolence—Methotrexate—psoriasis	0.000264	0.000517	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—psoriasis	0.000261	0.000512	CcSEcCtD
Amiloride—Vomiting—Betamethasone—psoriasis	0.000259	0.000508	CcSEcCtD
Amiloride—Vomiting—Dexamethasone—psoriasis	0.000259	0.000508	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—psoriasis	0.000258	0.000506	CcSEcCtD
Amiloride—Rash—Dexamethasone—psoriasis	0.000257	0.000504	CcSEcCtD
Amiloride—Rash—Betamethasone—psoriasis	0.000257	0.000504	CcSEcCtD
Amiloride—Dermatitis—Dexamethasone—psoriasis	0.000257	0.000503	CcSEcCtD
Amiloride—Dermatitis—Betamethasone—psoriasis	0.000257	0.000503	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—psoriasis	0.000256	0.000502	CcSEcCtD
Amiloride—Fatigue—Methotrexate—psoriasis	0.000256	0.000501	CcSEcCtD
Amiloride—Headache—Betamethasone—psoriasis	0.000255	0.000501	CcSEcCtD
Amiloride—Headache—Dexamethasone—psoriasis	0.000255	0.000501	CcSEcCtD
Amiloride—Asthenia—Prednisone—psoriasis	0.000255	0.000499	CcSEcCtD
Amiloride—Pain—Methotrexate—psoriasis	0.000254	0.000497	CcSEcCtD
Amiloride—Pruritus—Prednisone—psoriasis	0.000251	0.000492	CcSEcCtD
Amiloride—SLC9A1—Metabolism—CAT—psoriasis	0.000246	0.00104	CbGpPWpGaD
Amiloride—Feeling abnormal—Methotrexate—psoriasis	0.000244	0.000479	CcSEcCtD
Amiloride—SLC9A1—Disease—HLA-A—psoriasis	0.000244	0.00103	CbGpPWpGaD
Amiloride—Diarrhoea—Prednisone—psoriasis	0.000243	0.000476	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—psoriasis	0.000242	0.000476	CcSEcCtD
Amiloride—Nausea—Dexamethasone—psoriasis	0.000242	0.000475	CcSEcCtD
Amiloride—Nausea—Betamethasone—psoriasis	0.000242	0.000475	CcSEcCtD
Amiloride—Dizziness—Prednisone—psoriasis	0.000235	0.00046	CcSEcCtD
Amiloride—Abdominal pain—Methotrexate—psoriasis	0.000234	0.00046	CcSEcCtD
Amiloride—PLAU—Hemostasis—VEGFA—psoriasis	0.000229	0.000971	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOE—psoriasis	0.000228	0.000965	CbGpPWpGaD
Amiloride—Vomiting—Prednisone—psoriasis	0.000226	0.000442	CcSEcCtD
Amiloride—Rash—Prednisone—psoriasis	0.000224	0.000439	CcSEcCtD
Amiloride—Dermatitis—Prednisone—psoriasis	0.000224	0.000438	CcSEcCtD
Amiloride—Headache—Prednisone—psoriasis	0.000222	0.000436	CcSEcCtD
Amiloride—Asthenia—Methotrexate—psoriasis	0.000213	0.000417	CcSEcCtD
Amiloride—SLC9A1—Disease—NOS2—psoriasis	0.000212	0.0009	CbGpPWpGaD
Amiloride—Nausea—Prednisone—psoriasis	0.000211	0.000413	CcSEcCtD
Amiloride—Pruritus—Methotrexate—psoriasis	0.00021	0.000411	CcSEcCtD
Amiloride—SLC22A2—Metabolism—NDUFA5—psoriasis	0.000208	0.000882	CbGpPWpGaD
Amiloride—Diarrhoea—Methotrexate—psoriasis	0.000203	0.000398	CcSEcCtD
Amiloride—Dizziness—Methotrexate—psoriasis	0.000196	0.000385	CcSEcCtD
Amiloride—SLC22A1—Metabolism—NDUFA5—psoriasis	0.000194	0.000822	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CP—psoriasis	0.000194	0.00082	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOE—psoriasis	0.000191	0.000809	CbGpPWpGaD
Amiloride—Vomiting—Methotrexate—psoriasis	0.000189	0.00037	CcSEcCtD
Amiloride—Rash—Methotrexate—psoriasis	0.000187	0.000367	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—psoriasis	0.000187	0.000366	CcSEcCtD
Amiloride—Headache—Methotrexate—psoriasis	0.000186	0.000364	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CARM1—psoriasis	0.000185	0.000782	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CP—psoriasis	0.00018	0.000764	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2S1—psoriasis	0.000177	0.00075	CbGpPWpGaD
Amiloride—Nausea—Methotrexate—psoriasis	0.000176	0.000345	CcSEcCtD
Amiloride—SLC9A1—Disease—TYK2—psoriasis	0.000174	0.000737	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—psoriasis	0.000173	0.000734	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000172	0.000729	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—psoriasis	0.000166	0.000704	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2S1—psoriasis	0.000165	0.000699	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD4—psoriasis	0.000157	0.000666	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—psoriasis	0.000122	0.000516	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CARM1—psoriasis	8.65e-05	0.000366	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—psoriasis	8.51e-05	0.00036	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CARM1—psoriasis	8.06e-05	0.000341	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAT—psoriasis	5.32e-05	0.000225	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAT—psoriasis	4.96e-05	0.00021	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOE—psoriasis	4.13e-05	0.000175	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOE—psoriasis	3.85e-05	0.000163	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—psoriasis	3.6e-05	0.000152	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—psoriasis	3.36e-05	0.000142	CbGpPWpGaD
